Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SRD-002 by Sardocor for Diastolic Heart Failure (HFpEF): Likelihood of Approval
SRD-002 is under clinical development by Sardocor and currently in Phase II for Diastolic Heart Failure (HFpEF). According to GlobalData,...